Health and Healthcare
1489 Articles
Pfizer, Inc. (NYSE: PFE) looks good on the surface on its earnings report for the fourth quarter, but the company’s…
Tuesday is going to be full of major earnings reports, two of which are DJIA components. These are not the…
Pfizer Inc. (NYSE: PFE) has received approval from the US Food and Drug Administration to sell its kidney cancer drug,…
Jim Cramer has touted several DJIA upside calls in 2012, but on Monday’s MAD MONEY on CNBC Cramer touted Merck…
The tide of patent expirations that is washing over big pharmaceutical houses is cresting now and investors have begun looking…
A state appeals court in Pennsylvania has sided with two women who filed suit against drugmaker Pfizer Inc. (NYSE: PFE)…
For several years it has been the case that Amgen Inc. (NASDAQ: AMGN) was considered a biotech though it had at…
As each new year replaces the prior year, 24/7 Wall St. looks at the individual targets on all 30 Dow…
The lineup of the Dogs of the Dow, simply the ten highest dividend yield stocks of the thirty Dow Jones…
Throughout December we have been giving updates on dividends that will rise in the coming days and weeks from the…
Spending on advertising barely showed a pulse in the third quarter of 2011, growing by just 0.4%, according a report…
Congress, close to a budget agreement, may avoid a government shutdown. (Reuters) Washington Mutual shareholders and creditors set a deal…
We recently gave a full review of the DJIA components we expect to raise their dividend payouts in the weeks…
S&P may downgrade the EU and the largest eurozone banks. (Reuters) France and Germany continue to press new eurozone treaty measures…
Dividends are still rising and equity and income investors should expect more of the same for 2012. The Walt Disney Company…
Our top personal finance-related articles today. Your wallet will thank you later.